A guide to testosterone cypionate for male hypogonadism covering FDA approval, T-Trials evidence, dosing protocols, monitoring, side effects, and insurance coverage.
A guide to testosterone cypionate for secondary hypogonadism covering FDA approval status, T-Trials evidence, dosing protocols, fertility preservation, and monitoring benchmarks.
A guide to Kaiser Permanente formulary status, prior authorization criteria, step therapy requirements, and appeal strategies for testosterone cypionate coverage.
Testosterone cypionate can improve mood and energy but may cause irritability at high doses. See T-Trials data, onset timing, and dosing guidance.
A guide to testosterone cypionate safety in men and women aged 50 to 64, covering cardiovascular risks, hematologic effects, dosing, monitoring, and evidence from the T-Trials and beyond.
Why your testosterone cypionate therapy has stopped working, and what to do about it. MD-level guidance on diagnosing true non-response, adjusting protocols, and optimizing labs for men on TRT.
A guide to how testosterone enanthate affects appetite, hunger hormones, and food cravings in men with hypogonadism, with primary-literature citations throughout.
A comprehensive clinical review of testosterone enanthate use in patients with autoimmune conditions, covering immunomodulatory mechanisms, disease-specific risks, dosing considerations, and monitoring protocols backed by primary literature.
Evidence-based guide to testosterone enanthate for secondary hypogonadism: FDA status, dosing protocols, clinical trial data, side effects, and when fertility-sparing alternatives are preferred.
Evidence-based testosterone enanthate muscle preservation strategies covering dosing, resistance training protocols, nutrition, and monitoring. Reviewed by board-certified physicians.
A clinician-level review of testosterone enanthate safety during pregnancy and lactation, covering teratogenic risk, fetal virilization, breast-milk transfer, and evidence-based alternatives for women with low testosterone.
A breakdown of testosterone enanthate's legal status, scheduling, approved indications, and prescribing rules across the United States, European Union, Canada, and United Kingdom, with primary-source citations throughout.
A guide to switching testosterone enanthate to or from cypionate, undecanoate, pellets, and topicals. Covers pharmacokinetics, washout timing, dose conversion, and monitoring protocols with PubMed and FDA citations.
A week-by-week guide to what happens during your first month on testosterone enanthate, including timelines, clinical data, lab targets, and side-effect management.
Most pregnant women need a 25 to 50% levothyroxine increase by early pregnancy. See ATA TSH targets by trimester and the 4-week monitoring schedule.
Find out whether levothyroxine disqualifies you from blood donation, how the drug works, when it starts acting, and what to avoid while taking it. Reviewed by HealthRX.com physicians.
A guide to converting between levothyroxine and natural desiccated thyroid (NDT), with exact conversion ratios, T3 dosing protocols, weight-based levothyroxine dosing, and pregnancy adjustment guidelines.
A comprehensive clinical guide to NP Thyroid (desiccated thyroid extract), covering dosing, how it compares to levothyroxine, Armour Thyroid, Tirosint, and Cytomel, plus who makes the best candidate for each option.
After 40, hormonal shifts, muscle loss, and metabolic slowdown make standard calorie-cutting ineffective. Learn what the clinical evidence actually supports for sustainable fat loss at this life stage.
A complete clinical guide to oral micronized progesterone (Prometrium) titration schedules, including starting doses, escalation timing, continuous vs. Cyclic protocols, and evidence-based adjustment criteria.
A complete guide to obtaining a vaginal estradiol prescription in Washington, covering telehealth visits, labs, pharmacies, Medicaid prior authorization, and compounding options.
A guide to vaginal estradiol use in autoimmune disease, covering systemic absorption, disease-specific safety data, drug interactions, and monitoring recommendations for lupus, Sjögren syndrome, RA, and MS.
A clinician-level review of vaginal estradiol's long-term cardiovascular safety, including systemic absorption data, WHI subgroup analyses, and current NAMS/ACOG prescribing guidance for women with genitourinary syndrome of menopause.
A clinician-level guide to vaginal estradiol dosing, mechanism, and safety adjustments in patients with hepatic impairment, with PubMed- and FDA-cited evidence.
Learn whether your state Medicaid plan covers vaginal estradiol for genitourinary syndrome of menopause, what prior authorization criteria apply, how step therapy works, and how to appeal a denial.
A deep dive into how vaginal estradiol is absorbed, metabolized, and whether low-dose local therapy meaningfully affects resting energy expenditure, thermogenesis, or body composition in menopausal women.
A clinician-level guide to adjusting vaginal estradiol (Vagifem, Yuvafem, Imvexxy) dosing, formulation, and monitoring across seasons, with primary-literature citations and practical prescribing guidance.
A guide to bazedoxifene/conjugated estrogens (Duavee), covering how it works, who qualifies, clinical trial evidence, and how it compares to estradiol patches, gels, sprays, and oral forms.
A comparison of estradiol pellet therapy versus oral, patch, gel (Divigel), and spray delivery. Covers dosing, pharmacokinetics, safety data, and how to choose the right form for your menopause symptoms.
Evidence-based guide to HRT duration for women: how long hormone therapy is safe, what guidelines say, when to stop, and how it interacts with contraception and fertility.
Learn which hysterectomy details affect HRT, why ovary removal matters, and what to check in your operation report before discussing your treatment plan.
Alcohol is not named as an interaction on the oral Premarin or Duavee labels, but it is linked to higher breast-cancer risk and may worsen hot flashes.
Does HRT affect fertility? Learn how estrogen and progesterone therapy interacts with ovulation, pregnancy risk, and reproductive planning at every stage of life.
Can you take HRT if you have fibroids? Learn how estrogen and progesterone affect fibroid growth, which formulations are safest, and when HRT is appropriate for perimenopausal and postmenopausal women with fibroids.
A guide to hormone replacement therapy during perimenopause. Covers estrogen and progesterone options, safety data, timing, post-hysterectomy protocols, PCOS considerations, and late postmenopausal use.
A clinical comparison of hormone replacement therapy (HRT) and fezolinetant (Veozah) for menopause symptoms, covering efficacy, safety, delivery methods, and who should choose each option.
If you have a uterus and are considering HRT, you must take progestogen alongside estrogen to protect the uterine lining. This guide covers regimen types, doses, risks, and how to tailor therapy for perimenopause, late postmenopause, PCOS, and more.
A comprehensive clinical guide to managing menopause symptoms after breast cancer, including hot flashes, vaginal dryness, and GSM, with evidence-based hormonal and non-hormonal treatment options for survivors.
A guide to diagnosing menopause and perimenopause, covering FSH and estradiol testing, symptom criteria, differential diagnosis from thyroid disease, and evidence-based treatment options including HRT, GSM care, and sleep strategies.
Why women gain weight during menopause and perimenopause, what hormones are responsible, and which treatments including HRT, GLP-1s, and lifestyle changes have the strongest clinical evidence.
A guide to oral micronized progesterone (Prometrium), its role alongside estradiol therapy, dosing schedules, sleep and cardiovascular benefits, and how patches, gels, sprays, and pills differ for menopausal women.
A comparison of oral and transdermal estradiol for menopausal HRT, covering VTE risk, liver metabolism, dosing, bioidentical options, patches vs gels, and how to choose based on your health profile.
A complete clinical guide to ospemifene (Osphena), the FDA-approved SERM for dyspareunia and vulvovaginal atrophy, with comparisons to estradiol patch, pill, gel, and spray options for menopausal women.
Progesterone and progestins protect the uterine lining during HRT, but they differ in molecular structure, side-effect profiles, cardiovascular risk, and breast-cancer signal. This guide covers the clinical evidence so you can have an informed conversation with your prescriber.
Genitourinary syndrome of menopause (GSM) affects over 50% of postmenopausal women, causing vaginal dryness, painful sex, and urinary symptoms. Learn what causes GSM, how it's diagnosed, and which treatments, from local estradiol to ospemifene, have the strongest clinical evidence.
Menopause-related mood swings, anxiety, and emotional upheaval are real, measurable, and treatable. Learn the neuroscience behind hormonal mood changes and the evidence-based solutions that work.
Yes, menopause causes fatigue through hormonal shifts, sleep disruption, mood changes, and thyroid interactions. Learn the mechanisms, timeframes, and evidence-based treatments that actually work.
Menopause can change body odor via lower estrogen, sweating, and pH shifts. Learn what helps: HRT, vaginal estrogen, antiperspirants, and lifestyle steps.
Estrogen directly regulates collagen synthesis, degradation, and skin thickness. Learn exactly how perimenopause-driven estrogen decline accelerates collagen loss, what the research shows, and what clinical options exist.
A guide to evidence-based options for menopause hot flashes, distinguishing FDA-approved treatments, off-label prescriptions, and lifestyle approaches, with a framework for matching severity to next steps.
Menopause face and facial bone resorption are informal terms, not diagnoses. See what is known about estrogen loss and bone density after menopause.
Menopause belly and bloating are driven by estrogen decline, cortisol shifts, and gut microbiome changes. Learn the clinical causes and evidence-based relief strategies.
Perimenopause is the hormonal transition before menopause, lasting 2 to 10 years. Learn the symptoms, stages, hormone changes, and evidence-based treatment options prepared by the HealthRX.com Editorial Team.
Topical estrogen applied to the face may reduce wrinkles, restore skin thickness, and improve hydration during perimenopause and menopause. Learn the evidence, protocols, and risks prepared by the HealthRX.com Editorial Team.
Evidence-based guide to testosterone cream dosing for women, including vaginal estradiol cream dosing and PT-141 (bremelanotide) dosing. Learn recommended doses, application sites, monitoring, and safety considerations backed by clinical trials and guidelines.
A guide to the pharmacokinetic and pharmacodynamic interaction between trazodone and progesterone HRT, covering mechanism, severity, monitoring, dose adjustment, and patient counseling.
Learn how to access testosterone cypionate through FDA expanded access, compassionate use programs, PAPs, discount cards, and HSA/FSA accounts. 2025 guide.
A guide to the clinical interaction between vaginal estradiol and SNRIs such as venlafaxine and duloxetine, covering mechanism, monitoring, dosing, and patient counseling.
A comparison of testosterone gel (AndroGel), cypionate, enanthate, propionate, and pellets. Includes doses, pharmacokinetics, side effects, and how to choose the right TRT formulation.
Veterans face unique low-testosterone risk factors including combat-related TBI, PTSD, opioid use, and chemical exposures. This guide covers VA eligibility, dosing protocols, age-specific considerations, and what the evidence actually shows.